These findings suggest that PC4 protects ESCC cells from IR-induced death by enhancing the NHEJ-promoting activity of XLF and could be used as a novel radiosensitivity predictor and a promising therapeutic target for ESCCs. This evidence concerns the gene NHEJ1 and esophageal squamous cell carcinoma.